Physician profile
Peter T Pham
NPI 1003155946
$1,657.01
in general payments reported to CMS, 2019-2025
13 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $150 · 2021: $123 · 2022: $315 · 2023: $319 · 2024: $346 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743 · Entertainment: $95.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.50 |
| Entertainment | $95.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $367.79 | 2019-2024 | Total30, Dailies, Dailies Total1 |
| Bausch & Lomb Americas INC. | $308.74 | 2022-2025 | Infuse |
| Coopervision INC. | $211.50 | 2020-2024 | Misight Contact Lens |
| Rxsight INC | $189.60 | 2022-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $133.76 | 2019-2022 | |
| Dompe US, INC. | $121.81 | 2023 | Oxervate |
| Optos, INC. | $121.29 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $62.31 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $45.73 | 2020 | |
| Sight Sciences, INC. | $30.37 | 2022 | |
| Kala Pharmaceuticals, INC. | $27.43 | 2021 | |
| Abbvie INC. | $20.68 | 2022 | |
| Oasis Medical, INC. | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.